THE HUMAN IMMUNOME PROJECT
Dead / Abandoned — Abandoned — no statement of use filed (as of 27 Jun 2022)
What this means for you
This application is over — abandoned 27 Jun 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88444052
- Mark type
- Stylized text
- Filed
- 23 May 2019
- Published for opposition
- 30 Mar 2021
- Abandoned
- 27 Jun 2022
- Attorney of record
- AMANDA B SLADE
Goods and services
- Class 001 — Chemicals: chemical agents for scientific and research use used for modulating an immune response
- Class 005 — Pharmaceuticals: therapeutic products for medical purposes in the nature of biological preparations, biological tissue cultures and cell-based therapeutics in the nature of genetically modified cells used to modulate an immune response; pharmaceutical preparations and agents to modulate an immune response
Owner
- REPERTOIRE IMMUNE MEDICINES, INC., CAMBRIDGE, MA, US
- REPERTOIRE IMMUNE MEDICINES, INC., CAMBRIDGE, MA, US
- COGEN IMMUNE MEDICINE, INC., CAMBRIDGE, MA, US
- Cogen Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 27 Jun 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 27 Jun 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 20 Nov 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Nov 2021 — SOU EXTENSION 1 GRANTED
- 18 Nov 2021 — SOU EXTENSION 1 FILED
- 18 Nov 2021 — SOU TEAS EXTENSION RECEIVED
- 25 May 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 30 Mar 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 30 Mar 2021 — PUBLISHED FOR OPPOSITION
- 10 Mar 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 25 Feb 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Feb 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 24 Feb 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 23 Feb 2021 — ASSIGNED TO LIE
- 19 Feb 2021 — TEAS REQUEST FOR RECONSIDERATION RECEIVED